ATP5B原核表达和单克隆抗体的制备及其鉴定

doi:10.13481/j.1671-587x.20190135

吉林大学学报(医学版) ›› 2019, Vol. 45 ›› Issue (01): 184-189.doi: 10.13481/j.1671-587x.20190135

• 方法学 • 上一篇

ATP5B原核表达和单克隆抗体的制备及其鉴定

李时孟¹, 赵丽纯², 乔璐¹, 何成彦¹, 刘卓³

1. 吉林大学中日联谊医院检验科, 吉林长春 130033;
2. 吉林大学药学院微生物与生化药学教研室, 吉林长春 130021;
3. 吉林大学中日联谊医院血管外科, 吉林长春 130033

收稿日期:2018-09-03 发布日期:2019-01-28
通讯作者: 刘卓,副主任医师(Tel:0431-84997828,E-mail:lzhuo@jlu.edu.cn) E-mail:lzhuo@jlu.edu.cn
作者简介:李时孟(1990-),女,吉林省长春市人,在读医学博士,主要从事肿瘤蛋白组学方面的研究。

Prokaryotic expressionof ATP5B and preparation and identification of its monoclonal antibody

LI Shimeng¹, ZHAO Lichun², QIAO Lu¹, HE Chengyan¹, LIU Zhuo³

1. Department of Clinical Laboratory, China-Japan Union Hospital, Jilin University, Changchun 130033, China;
2. Department of Microbiology and Biochemical Pharmacy, School of Pharmacy, Jilin University, Changchun 130021, China;
3. Department of Vascular Surgery, China-Japan Union Hospital, Jilin University, Changchun 130033, China

Received:2018-09-03 Published:2019-01-28
Contact: 国家自然科学基金资助课题（81572082，81472454）；吉林省科技厅科研基金资助课题（20150414015GH） E-mail:lzhuo@jlu.edu.cn

摘要/Abstract

摘要： 目的：制备高纯度ATP合酶β亚基（ATP5B）单克隆抗体并进行鉴定，为其后续研究奠定基础。方法：应用PCR法扩增ATP5B基因，克隆入pET28a载体中并转入大肠杆菌BL21（DE3）。异丙基-β-D-硫代吡喃半乳糖苷（IPTG）诱导蛋白表达并用镍亲和层析柱纯化融合蛋白，SDS-聚丙烯酰胺凝胶电泳（SDS-PAGE）检测蛋白纯度。用纯化的融合蛋白免疫3只雌性Balb/C小鼠，取小鼠尾静脉血，间接酶联免疫吸附法（ELISA法）检测血清中ATP5B抗体效价。取血清效价最高的免疫小鼠脾细胞与小鼠骨髓瘤SP2/0细胞混合培养建立杂交瘤细胞，采用间接ELISA法筛选融合细胞并行单克隆化培养，对阳性细胞进行核型分析。取12周龄Balb/C小鼠，腹腔注射杂交瘤细胞制备腹水模型，收集腹水，间接ELISA法检测效价，SDS-PAGE检测抗体纯度，应用ELISA法检测抗体亚型。结果：PCR扩增后得到1 455bp的特异性条带，连接pET28a空载体获得重组pET28a/ATP5B载体。IPTG诱导转化的菌液表达目的蛋白，SDS-PAGE检测，在相对分子质量为51 000处出现明显的诱导蛋白条带。间接ELISA法检测免疫小鼠静脉血，血清效价最高达1：64 000。杂交瘤细胞染色体核型分析，染色体总数约为骨髓瘤细胞与正常小鼠脾细胞之和。采用杂交瘤细胞株制备小鼠腹水，抗体最高效价为1：240 000，杂交瘤细胞产生的单克隆抗体的亚型为IgG1。结论：通过克隆、表达和纯化重组蛋白，成功制备出抗ATP5B蛋白单克隆抗体。

关键词: ATP合酶β亚基, 单克隆抗体, 原核表达, 蛋白纯化

Abstract: Objective: To construct and identify the monoclonal antibody of ATP synthase beta subunit(ATP5B) with high purity, and to lay foundation for further study.Methods: The ATP5B gene was amplified by PCR and cloned into the pET28a vector and transformed into E. coli BL21 (DE3). The protein expression was induced by IPTG and then the fusion protein was purified by nickel affinity chromatography column. The protein purity was detected by SDS-polyacrylamide gel electrophoresis (SDS-PAGE). Three female Balb/C mice were immunized with purified fusion protein and the tail vein blood was taken to detect the titer of ATP5B antibody by indirect enzyme-linked immunosorbent assay (ELISA). The spleen cells from the immunized mice with the highest serum titer were mixed with the SP2/0 cells to establish the hybridoma cells and the fused cells were screened by indirect ELISA and monoclonally cultured. Karyotype analysis were performed in the positive cells. The hybridoma cells were intraperitoneally injected into 12 weeks old BALB/C mice to estabilish the ascites models. The titer of ascites was detected by indirect ELISA. The purity of the antibody was detected by SDS-PAGE. The antibody subtype was detected by ELISA.Results: After PCR amplification, a specific band of 1 455bp was obtained, and the pET28a empty vector was ligated to obtain a recombinant pET28a/ATP5B vector. The target protein was expressed in the IPTG-induced bacteria solution; the SDS-PAGE results showed that the protein band was found at 51 000. The indirect ELISA results showed that the serum titer of the venous blood of immunized mice was up to 1:64 000. In karyotype analysis, the total number of chromosomes in hybridoma cells was about the sum of myeloma cells and normal mouse spleen cells. The mouse ascites was prepared with the hybridoma cell line, and the highest titer of the antibody was 1:240 000. The subtype of the monoclonal antibody produced by the hybridoma cells was IgG1.Conclusion: The monoclonal antibody against ATP5B protein is successfully prepared by cloning, expressing and purifying the recombinant protein.

Key words: ATP synthase beta subunit, monoclonal antibody, prokaryotic expression, protein purification

中图分类号:

李时孟, 赵丽纯, 乔璐, 何成彦, 刘卓. ATP5B原核表达和单克隆抗体的制备及其鉴定[J]. 吉林大学学报(医学版), 2019, 45(01): 184-189.

LI Shimeng, ZHAO Lichun, QIAO Lu, HE Chengyan, LIU Zhuo. Prokaryotic expressionof ATP5B and preparation and identification of its monoclonal antibody[J]. Journal of Jilin University(Medicine Edition), 2019, 45(01): 184-189.

参考文献

[1] WALLACE D C. Mitochondria and cancer[J].Nat Rev Cancer, 2012, 12(10):685-698.
[2] TAN A S,BATY J W,DONG L F, et al. Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA[J]. Cell Metab, 2015, 21(1):81-94.
[3] FORMENTINI L,MARTÍNEZ-REYES I, CUEZVA J M. The mitochondrial bioenergetic capacity of carcinomas[J]. IUBMB Life, 2010, 62(7):554-560.
[4] SENIOR A E. ATP synthase:motoring to the finish line[J]. Cell, 2007, 130(2):220-221.
[5] GEYIK E,IGCI Y Z,PALA E, et al. Investigation of the association between ATP2B4 and ATP5B genes with colorectal cancer[J]. Gene, 2014, 540(2):178-182.
[6] XU G,LI J Y. ATP5A1 and ATP5B are highly expressed in glioblastoma tumor cells and endothelial cells of microvascular proliferation[J]. J Neurooncol, 2016, 126(3):405-413.
[7] SUN J,YANG Z L,MIAO X, et al. ATP5b and β2-microglobulin are predictive markers for the prognosis of patients with gallbladder cancer[J]. J Mol Histol, 2015, 46(1):57-65.
[8] LU Z, SONG Q, SONG Q, et al. Preparation of monoclonal antibody against lung cancer and identification of its targeting antigen[J]. J Biomed Engineering, 2010, 27(1):147-151.
[9] 刘素霞. 重组单克隆抗体生产的宿主细胞系的研究进展[J]. 科技风, 2018, 9(25):36.
[10] SALTZ L. Systemic therapy for metastatic colorectal cancer[J]. J Natl Compr Canc Netw, 2013, 11(Suppl 5):649-652.
[11] SALTZ L B,LENZ H J,KINDLER H L, et al. Randomized phase Ⅱ trial of cetuximab,bevacizumab and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer:the BOND-2 study[J]. J Clin Oncol, 2007, 25(29):4557-4561.
[12] 邓云秋. EGFR单克隆抗体靶向药物治疗脑胶质瘤的研究进展[J]. 中国处方药, 2018, 16(8):22-23.
[13] 朱慧,李春蕊. 多发性骨髓瘤的免疫治疗进展[J]. 医药导报, 2018, 37(10):1160-1165.
[14] 赵源浩. 靶向抗肿瘤单克隆抗体类药物联合常规化疗方案治疗转移性结直肠癌的临床进展[J]. 中国药房, 2018, 29(14):2012-2016.
[15] 刘志, 赵春清, 张彬, 等. VEGF、Bmi-1在结肠癌组织中的表达及意义[J].河北医药, 2016, 38(20):3104-3106.
[16] GREENING D W,LEE S T,JI H, et al. Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumoursreveals perturbations in metabolic and hypoxic response pathways[J]. Oncotarget, 2015, 6(35):38166-38180.
[17] SÁNCHEZ-ARAGÓ M, CHAMORRO M, CUEZVA JM. Selection of cancer cells with repressed mitochondria triggers colon cancer progression[J]. Carcinogenesis, 2010, 31(4):567-576.
[18] REN L R,ZHANG L P,HUANG S Y,et al. Effects of sialidase NEU1 siRNA on proliferation, apoptosis, and invasion in human ovarian cancer[J]. Mol Cell Biochem, 2016, 411(1/2):213-219.
[19] FLIEDNER S M, YANG C,THOMPSON E, et al. Potential therapeutic target for malignant paragangliomas:ATP synthase on the surface of paraganglioma cells[J]. Am J Cancer Res, 2015, 5(4):1558-1570.
[20] LI W, LI Y, LI G, et al. Ectopic expression of the ATP synthase β subunit on the membrane of PC-3M cells supports its potential role in prostate cancer metastasis[J]. Int J Oncol, 2017, 50(4):1312-1320.
[21] LYNAM-LENNON N, Maher SG, Maguire A, et al. Altered mitochondrial function and energy metabolism is associated with a radioresistant phenotype in oesophageal adenocarcinoma[J]. PLoS ONE, 2014, 9(6):e100738.
[22] XIAO X, YANG J, LI R, et al. Deregulation of mitochondrial ATPsyn-β in acute myeloid leukemia cells and with increased drug resistance[J]. PLoS ONE, 2013, 8(12):e83610.
[23] 蒋灵旭,罗颖婉,佟红艳.急性髓系白血病靶向治疗新进展[J].中国实用内科杂志,2018,38(12):1198-1202.

ATP5B原核表达和单克隆抗体的制备及其鉴定

Prokaryotic expressionof ATP5B and preparation and identification of its monoclonal antibody

RichHTML

PDF (PC)

赞

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

本文评价

推荐阅读 0

[1]	李会敏, 伊焕发. 刚地弓形虫肌动蛋白profilin的原核表达和纯化[J]. 吉林大学学报(医学版), 2017, 43(06): 1109-1114.
[2]	邵敏, 王新颖, 刘星, 王燕, 周鹤峰, 葛正龙. hISO基因原核表达载体的构建及其在大肠杆菌中的表达及鉴定[J]. 吉林大学学报(医学版), 2016, 42(01): 59-63.
[3]	李松，杨立彬，张舒岩，金羽，陈秀华，李新，刘玲，李树蕾,李树红. 建鲤重组Cystatin蛋白的原核表达、鉴定及多克隆抗体制备[J]. 吉林大学学报(医学版), 2014, 40(01): 204-209.
[4]	苏雅拉图，张永胜，陈宇杰，胡小平，王丽颖，万敏，吴柒柱. 重组小鼠IFN-β原核表达载体的构建及包涵体溶解条件的筛选[J]. 吉林大学学报(医学版), 2013, 39(4): 841-846.
[5]	宋天一，李菁华，张哲，史红艳,孙延波 . 蜱传森林脑炎病毒非结构蛋白1原核表达载体的构建[J]. 吉林大学学报(医学版), 2013, 39(3): 620-624.
[6]	刘彤，李洋，李丹妮*，耿楠希，李丰. 人p21活化激酶6基因截短区域的GST标签原核表达质粒的构建及其重组蛋白的表达[J]. 吉林大学学报(医学版), 2013, 39(3): 437-440.
[7]	张士尧\|浦昀\|徐坤\|李金华\|原野\|鞠文\|李娟. 重组钩端螺旋体多抗原位点同源合成基因的表达及其抗原性鉴定[J]. J4, 2012, 38(3): 404-408.
[8]	杨南扬, 缪璇, 伍贤军, 刘金美, 辻一郎, 李晓萌. 类泛素化修饰蛋白SUMO3 /GST融合蛋白表达载体的构建及表达[J]. J4, 2011, 37(6): 1010-1014.
[9]	陈光\|吴铭\|王刚\|孙旸. 重组人胶原蛋白肽在大肠杆菌中的高效表达[J]. J4, 2011, 37(4): 656-660.
[10]	徐丽娟,温剑平,史红艳,孙延波 . 人乳头瘤病毒16型E7基因原核表达载体的构建及表达[J]. J4, 2011, 37(4): 661-664.
[11]	赵彤, 王秀兰, 刘勇, 王若雨. 表皮生长因子受体单克隆抗体对辐射诱导肺腺癌细胞SPC-A-1的增敏作用[J]. J4, 2011, 37(3): 483-486.
[12]	关锋\|林秋玉\|赵红光\|林承赫. 恶性肿瘤放射免疫治疗的研究进展[J]. J4, 2011, 37(1): 179-183.
[13]	张耀方, 万晓珊, 赵宏鑫, 邵明龙, 杨苹, 孔祥鑫, 刘敏, 李校堃, 王会岩. FGF21［Tyr²⁰］突变体的克隆、表达及纯化[J]. J4, 2010, 36(6): 1088-1093.
[14]	周静，马吉春，赵小霞，方芳，宋献美，柳忠辉，台桂香. 重组人IL2-MUC1融合蛋白在大肠杆菌中的表达及鉴定[J]. J4, 2008, 34(5): 763-766.
[15]	杨立彬，李树蕾，谭岩，许淑芬，汪军. rhTL1A基因原核表达载体的构建、表达与纯化[J]. J4, 2008, 34(3): 415-419.